Vascular Markers During OGTT in Diabetics and First-degree Relatives
Changes of the Endothelial Glycocalyx, the Elastic Properties of the Arteries and the Coronary Flow Reserve (CFR) During Oral Glucose Tolerance Test in Patients With New Onset Diabetes Mellitus and First-degree Relatives
1 other identifier
observational
100
1 country
1
Brief Summary
Arterial stiffness is associated with increased risk for cardiovascular disease. Moreover, the integrity of endothelial glycocalyx plays a vital role in vascular permeability, inflammation and elasticity. The association between damage of endothelial glycocalyx, impaired arterial elastic properties, and CFR in diabetics and first degree relatives has not been explored. The purpose of this study is to explore the association between damage of endothelial glycocalyx, impaired arterial elastic properties, and CFR in diabetics and first-degree relatives before and after during oral glucose tolerance test (OGTT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 15, 2014
CompletedFirst Posted
Study publicly available on registry
September 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedMarch 4, 2019
October 1, 2018
1.8 years
September 15, 2014
February 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Differences of vascular function at baseline and during OGTT among the 3 groups.
Differences of pulse wave velocity, augmentation index and central aortic blood pressure at baseline and during OGTT among the 3 groups.
Baseline, 30 min, 60 min, 90 min, and 120 min during OGTT.
Differences of endothelial function at baseline and during OGTT among the 3 groups.
Differences of coronary flow reserve and endothelial glycocalyx thickness at baseline and during OGTT among the 3 groups.
Baseline, 30 min, 60 min, 90 min, and 120 min during OGTT.
Secondary Outcomes (2)
Insulin resistance and arterial stiffness
Baseline, 30 min, 60 min, 90 min, and 120 min during OGTT.
Insulin resistance and endothelial function
Baseline, 30 min, 60 min, 90 min,120 min of OGTT
Study Arms (3)
Controls
Subjects with no family history of diabetes mellitus and normal OGTT
Relatives
First-degree relatives of patients with diabetes mellitus and normal OGTT
Diabetics
Subjects with abnormal OGTT
Eligibility Criteria
90 subjects, 30 first degree relatives of diabetics withnormal OGTT (relatives), 30 withnormal OGTT and no family history of diabetes (normals), and 30 with abnormal OGTT (diabetics).
You may qualify if:
- subjects without known diabetes
- first degree relatives of diabetics
You may not qualify if:
- coronary or valvular heart disease
- congestive heart failure
- peripheral vascular disease
- liver or kidney failure
- history of alcohol or drug abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
''Attikon'' University General Hospital
Athens, Attica, 12462, Greece
Related Publications (1)
Ikonomidis I, Lambadiari V, Pavlidis G, Koukoulis C, Kousathana F, Varoudi M, Spanoudi F, Maratou E, Parissis J, Triantafyllidi H, Paraskevaidis I, Dimitriadis G, Lekakis J. Insulin resistance and acute glucose changes determine arterial elastic properties and coronary flow reserve in dysglycaemic and first-degree relatives of diabetic patients. Atherosclerosis. 2015 Aug;241(2):455-62. doi: 10.1016/j.atherosclerosis.2015.06.006. Epub 2015 Jun 9.
PMID: 26081121DERIVED
Biospecimen
Plasma in serum for fibrosis and inflammatory markers
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ignatios Ikonomidis, MD
2nd Cardiology Department, University of Athens, Greece
- PRINCIPAL INVESTIGATOR
George Pavlidis, MD
2nd Cardiology Department, University of Athens, Greece
- PRINCIPAL INVESTIGATOR
Vaia Lambadiari, MD
2nd Department of Internal Medicine , University of Athens, Greece
- PRINCIPAL INVESTIGATOR
Charalambos Koukoulis, MD
2nd Cardiology Department, University of Athens, Greece
- PRINCIPAL INVESTIGATOR
Fotini Kousathana, MD
2nd Department of Internal Medicine, University of Athens, Greece
- PRINCIPAL INVESTIGATOR
Maria Varoudi, MD
2nd Cardiology Department, University of Athens, Greece
- PRINCIPAL INVESTIGATOR
Vlasios Tritakis, MD
2nd Cardiology Department, University of Athens, Greece
- PRINCIPAL INVESTIGATOR
Helen Triantafyllidi, MD
2nd Cardiology Department, University of Athens, Greece
- PRINCIPAL INVESTIGATOR
George Dimitriadis, MD
2nd Department of Internal Medicine, University of Athens, Greece
- PRINCIPAL INVESTIGATOR
John Lekakis, MD
2nd Cardiology Department, University of Athens, Greece
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor in Cardiology
Study Record Dates
First Submitted
September 15, 2014
First Posted
September 19, 2014
Study Start
February 1, 2013
Primary Completion
December 1, 2014
Study Completion
March 1, 2015
Last Updated
March 4, 2019
Record last verified: 2018-10